New patent for Epizyme Inc drug TAZVERIK
Annual Drug Patent Expirations for TAZVERIK Tazverik is a drug marketed by Epizyme Inc and is included in one NDA. There are twenty-three patents protecting this drug. This drug has…
The post New patent for Epizyme Inc drug TAZVERIK appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.